These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28043654)

  • 1. Selected flavonoid compounds as promising inhibitors of protein kinase CK2α and CK2α', the catalytic subunits of CK2.
    Baier A; Galicka A; Nazaruk J; Szyszka R
    Phytochemistry; 2017 Apr; 136():39-45. PubMed ID: 28043654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward selective CK2alpha and CK2alpha' inhibitors: Development of a novel whole-cell kinase assay by Autodisplay of catalytic CK2alpha'.
    Bollacke A; Nienberg C; Borgne ML; Jose J
    J Pharm Biomed Anal; 2016 Mar; 121():253-260. PubMed ID: 26786382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical characterization of CK2alpha and alpha' paralogues and their derived holoenzymes: evidence for the existence of a heterotrimeric CK2alpha'-holoenzyme forming trimeric complexes.
    Olsen BB; Rasmussen T; Niefind K; Issinger OG
    Mol Cell Biochem; 2008 Sep; 316(1-2):37-47. PubMed ID: 18574672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory influence of natural flavonoids on human protein kinase CK2 isoforms: effect of the regulatory subunit.
    Baier A; Nazaruk J; Galicka A; Szyszka R
    Mol Cell Biochem; 2018 Jul; 444(1-2):35-42. PubMed ID: 29188536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the human protein kinase CK2 catalytic subunit CK2α' and interaction thermodynamics with the regulatory subunit CK2β.
    Bischoff N; Olsen B; Raaf J; Bretner M; Issinger OG; Niefind K
    J Mol Biol; 2011 Mar; 407(1):1-12. PubMed ID: 21241709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A N-terminally deleted form of the CK2α' catalytic subunit is sufficient to support cell viability.
    Borgo C; D'Amore C; Cesaro L; Itami K; Hirota T; Salvi M; Pinna LA
    Biochem Biophys Res Commun; 2020 Oct; 531(3):409-415. PubMed ID: 32800562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Plasticity of Crystalline CK2α' Leads to KN2, a Bivalent Inhibitor of Protein Kinase CK2 with Extraordinary Selectivity.
    Lindenblatt D; Applegate V; Nickelsen A; Klußmann M; Neundorf I; Götz C; Jose J; Niefind K
    J Med Chem; 2022 Jan; 65(2):1302-1312. PubMed ID: 34323071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CK2α and CK2α' subunits differ in their sensitivity to 4,5,6,7-tetrabromo- and 4,5,6,7-tetraiodo-1H-benzimidazole derivatives.
    Janeczko M; Orzeszko A; Kazimierczuk Z; Szyszka R; Baier A
    Eur J Med Chem; 2012 Jan; 47(1):345-50. PubMed ID: 22115617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing the convergence of protein kinase CK2 and caspase-3 reveals isoform-specific phosphorylation of caspase-3 by CK2α': implications for pathological roles of CK2 in promoting cancer cell survival.
    Turowec JP; Vilk G; Gabriel M; Litchfield DW
    Oncotarget; 2013 Apr; 4(4):560-71. PubMed ID: 23599180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a CK2α'-Biased ATP-Competitive Inhibitor from a High-Throughput Screen of an Allosteric-Inhibitor-Like Compound Library.
    Mudaliar D; Mansky RH; White A; Baudhuin G; Hawkinson J; Wong H; Walters MA; Gomez-Pastor R
    ACS Chem Neurosci; 2024 Aug; 15(15):2703-2718. PubMed ID: 38908003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and characterization of the CK2alpha'-based holoenzyme, an isozyme of CK2alpha: a comparative analysis.
    Olsen BB; Boldyreff B; Niefind K; Issinger OG
    Protein Expr Purif; 2006 Jun; 47(2):651-61. PubMed ID: 16442308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene targeting of CK2 catalytic subunits.
    Seldin DC; Lou DY; Toselli P; Landesman-Bollag E; Dominguez I
    Mol Cell Biochem; 2008 Sep; 316(1-2):141-7. PubMed ID: 18594950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential localization of alpha' and beta subunits of protein kinase CK2 during rat spermatogenesis.
    Alvarado-Díaz CP; Tapia JC; Antonelli M; Moreno RD
    Cell Tissue Res; 2009 Oct; 338(1):139-49. PubMed ID: 19711102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducible expression of protein kinase CK2 in mammalian cells. Evidence for functional specialization of CK2 isoforms.
    Vilk G; Saulnier RB; St Pierre R; Litchfield DW
    J Biol Chem; 1999 May; 274(20):14406-14. PubMed ID: 10318865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of CKIP-1, a novel pleckstrin homology domain-containing protein that interacts with protein kinase CK2.
    Bosc DG; Graham KC; Saulnier RB; Zhang C; Prober D; Gietz RD; Litchfield DW
    J Biol Chem; 2000 May; 275(19):14295-306. PubMed ID: 10799509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel potent, selective and cell permeable inhibitor of protein kinase CK2 from the NIH/NCI Diversity Set Library.
    Guerra B; Hochscherf J; Jensen NB; Issinger OG
    Mol Cell Biochem; 2015 Aug; 406(1-2):151-61. PubMed ID: 25963666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional specialization of CK2 isoforms and characterization of isoform-specific binding partners.
    Litchfield DW; Bosc DG; Canton DA; Saulnier RB; Vilk G; Zhang C
    Mol Cell Biochem; 2001 Nov; 227(1-2):21-9. PubMed ID: 11827170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The alpha catalytic subunit of protein kinase CK2 is required for mouse embryonic development.
    Lou DY; Dominguez I; Toselli P; Landesman-Bollag E; O'Brien C; Seldin DC
    Mol Cell Biol; 2008 Jan; 28(1):131-9. PubMed ID: 17954558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unexpected Binding Mode of a Potent Indeno[1,2-b]indole-Type Inhibitor of Protein Kinase CK2 Revealed by Complex Structures with the Catalytic Subunit CK2α and Its Paralog CK2α'.
    Hochscherf J; Lindenblatt D; Witulski B; Birus R; Aichele D; Marminon C; Bouaziz Z; Le Borgne M; Jose J; Niefind K
    Pharmaceuticals (Basel); 2017 Dec; 10(4):. PubMed ID: 29236079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic administration of antisense oligonucleotides simultaneously targeting CK2α and α' subunits reduces orthotopic xenograft prostate tumors in mice.
    Trembley JH; Unger GM; Tobolt DK; Korman VL; Wang G; Ahmad KA; Slaton JW; Kren BT; Ahmed K
    Mol Cell Biochem; 2011 Oct; 356(1-2):21-35. PubMed ID: 21761204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.